NIKKEI 225
27,693.65 +184.19 (+0.67%) HANG SENG
21,222.16 -438.31 (-2.02%) CRUDE OIL
73.58 +0.19 (+0.26%) GOLD FUTURES
1,877.50 +0.90 (+0.05%) DOW
33,862.86 -63.15 (-0.19%) BTC-GBP
19,186.27 -20.93 (-0.11%)
MorphoSys AG (MOR.DE)
| Previous close | 19.00 |
| Open | 18.72 |
| Bid | 18.85 x 1500 |
| Ask | 18.89 x 8800 |
| Day's range | 18.42 - 19.05 |
| 52-week range | 11.81 - 28.31 |
| Volume | |
| Avg. volume | 336,191 |
| Market cap | 650.761M |
| Beta (5Y monthly) | 0.73 |
| PE ratio (TTM) | 6.41 |
| EPS (TTM) | 2.97 |
| Earnings date | 17 Nov 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 32.96 |
- EQS Group
MorphoSys AG: MorphoSys Expects Topline Data from Phase 3 Study of Pelabresib in Myelofibrosis in Early 2024
EQS-News: MorphoSys AG / Key word(s): ConferenceMorphoSys AG: MorphoSys Expects Topline Data from Phase 3 Study of Pelabresib in Myelofibrosis in Early 2024 09.01.2023 / 07:01 CET/CESTThe issuer is solely responsible for the content of this announcement.Media ReleasePlanegg/Munich, Germany, January 9, 2023 MorphoSys Expects Topline Data from Phase 3 Study of Pelabresib in Myelofibrosis in Early 2024MorphoSys AG (FSE: MOR; NASDAQ: MOR) announced today that topline data from the ongoing Phase 3 MA
- Simply Wall St.
Investors in MorphoSys (ETR:MOR) have unfortunately lost 90% over the last three years
As every investor would know, not every swing hits the sweet spot. But really big losses can really drag down an...
- EQS Group
MorphoSys Reports Preliminary 2022 Monjuvi U.S. Net Product Sales, Provides 2023 Financial Guidance and Reduces Financial Liability
EQS-News: MorphoSys AG / Key word(s): ForecastMorphoSys Reports Preliminary 2022 Monjuvi U.S. Net Product Sales, Provides 2023 Financial Guidance and Reduces Financial Liability 05.01.2023 / 11:38 CET/CESTThe issuer is solely responsible for the content of this announcement.Media Release Planegg/Munich, Germany, January 5, 2023 MorphoSys Reports Preliminary 2022 Monjuvi U.S. Net Product Sales, Provides 2023 Financial Guidance and Reduces Financial Liability Preliminary 2022 Monjuvi U.S. net prod
